07/2013 - Državni zavod za intelektualno vlasništvo
12.07.2015 • Views
Share Embed Flag

07/2013 - Državni zavod za intelektualno vlasništvo

07/2013 - Državni zavod za intelektualno vlasništvo

07/2013 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
dziv.hr

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 20, <strong>2013</strong>, 7, 2169 – 2293 2219(51) MKPC<strong>07</strong>D 317/58 (2006.01) (97) EP 2612858C<strong>07</strong>D 405/12 (2006.01)(96) EP 13153028.9 02.10.20<strong>07</strong>.(97) EP 2612858, 10.<strong>07</strong>.<strong>2013</strong>. <strong>2013</strong>28, En(31) 2006271172 (32) 02.10.2006. (33) JP(54) STAT3/5 activation inhibitor(71) OTSUKA PHARMACEUTICAL CO., LTD., 9, Kanda Tsukasamachi2-chome, Chiyoda-kuTokyo 101-8535, JP(72) Sekiguchi, Kazuo, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPSuzuki, Takashi, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPOhbuchi, Yutaka, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPOkuno, Mitsuhiro, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPOhi, Naoto, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPOhnishi, Kenji, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPMotoyama, Masaaki, c/o OTSUKA PHARMACEUTICAL CO.,LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPYoshida, Kenji, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPKodama, Takeshi, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPSugiyama, Kazuhisa, c/o OTSUKA PHARMACEUTICAL CO.,LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPAkamatsu, Seiji, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPKiyono, Kunihiko, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPYanagihara, Yasuo, c/o OTSUKA PHARMACEUTICAL CO.,LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPWatanabe, Takashi, c/o OTSUKA PHARMACEUTICAL CO.,LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPHayashi, Kazuhiko, c/o OTSUKA PHARMACEUTICAL CO.,LTD.11-1, Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPTanaka, Hideo, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JPSumida, Takumi, c/o OTSUKA PHARMACEUTICAL CO., LTD.11-1,Karasaki 1-chomeOtsu-shi, Shiga, 520-0106, JP(51) MKPC<strong>07</strong>D 401/04 (2006.01) (97) EP 2522664C<strong>07</strong>D 413/04 (2006.01)A61K 31/4545 (2006.01)(96) EP 12169655.3 29.06.2005.(97) EP 2522664, 14.11.2012. 201246, En(31) 584502 P (32) 01.<strong>07</strong>.2004. (33) US(54) Piperidine derivatives as NK1 antagonists(71) OPKO Health, Inc., 4400 Biscayne Blvd., Miami, FL 33137, US(72) Palani, Anandan, 25 Reinhart Way, Bridgewater, NJ New Jersey088<strong>07</strong>, USShih, Neng-Yang, 4 Overlook Drive, Warren, NJ New Jersey <strong>07</strong>059,USHuang, Xianhai, 16 Hemlock Circle, Warren, NJ New Jersey <strong>07</strong>059,USXiao, Dong, 199 King George Road, Warren, NJ New Jersey<strong>07</strong>059, USPaliwal, Sunil, 5 Golf View Court, Monroe Township, NJ New Jersey08831, USTsui, Hon-Chung, 41 Cortland Drive, East Brunswick, NJ NewJersey 08816, USWrobleski, Michelle Laci, 15<strong>07</strong> South Branch Drive, WhitehouseStation, NJ New Jersey 08889, USRao, Ashwin U., 806 Evergreen Forest Boulevard, Avenel, NJ NewJersey <strong>07</strong>001, USWang, Cheng, 540 Stevens Drive Apt. 314, King of Prussia, PAPennsylvania 19406, USShah, Sapna S., 3 Augusta Drive, Westampton, NJ New Jersey08060, US(51) MKPC<strong>07</strong>D 401/14 (2006.01) (97) EP 2535338A61K 31/4545 (2006.01)A61P 3/10 (2006.01)C<strong>07</strong>D 401/04 (2006.01)(96) EP 12162956.2 19.<strong>07</strong>.20<strong>07</strong>.(97) EP 2535338, 19.12.2012. 201251, En(31) 8<strong>07</strong>901 P (32) 20.<strong>07</strong>.2006. (33) US(54) Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxypyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile(71) AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, US(72) McDermott, Todd, S., 112 Douglas Avenue, Libertyville, IL Illinois60048, USBorchardt, Thomas, B., 2433 55th Avenue, Kenosha, WI Wisconsin53144, USWagaw, Seble, H., 2311 Ridgeway Avenue, Evanston, IL Illinois60201, USEngstrom, Kenneth, M., 96 Alexandria Court, Mundelein, IL Illinois60060, USGandarilla, Jorge, 2228 Lathrop Avenue, North Riverside, IL Illinois60546, USKruger, Albert, 3310 121st Place, Pleasant Prairie, WI Wisconsin53158, USRozema, Michael, J., 5215 41st Street, Kenosha, WI Wisconsin53144, USFickes, Michael, G., 2311 Ridgeway Avenue, Evanston, IL Illinois60201, USWittenberger, Steven, J., 45 S. Pershing Avenue, Mundelein, ILIllinois 60060, USBhagavatula, Lakshmi, 272 Noble Circle, Vernon Hills, IL Illinois60061, US(51) MKPC<strong>07</strong>D 405/12 (2006.01) (97) EP 2311827(96) EP 10194614.3 23.08.2005.(97) EP 2311827, 20.04.2011. 201116, En(31) 0419235 (32) 28.08.2004. (33) GB0502544 08.02.2005. GB(54) Thiopyrimidine derivative, useful as an intermediate forchemokine receptor modulators.(71) AstraZeneca AB, , 151 85 Södertälje, SE(72) Cheshire, David, Ranulf, AstraZeneca R&D Charnwood BakewellRoad, Loughborough, Leicestershire LE11 5RH, GBCox, Rhona, Jane, AstraZeneca R&D Charnwood Bakewell Road,Loughborough, Leicestershire LE11 5RH, GBMeghani, Premji, c/o AstraZeneca Intellectual Property AstraZenecaR&D AlderleyAlderley Park, Macclesfield, Cheshire SK10 4TG, GBPreston, Cherylin, Francis, C/o AstraZeneca IPAstraZeneca R&DAlderley Alderley Park, Macclesfield, Cheshire, SK10 4TG, GBSmith, Michael, Neal C/o AstraZeneca IP, AstraZeneca R&DAlderley, Alderley Park, MacclesfieldCheshire, SK10 4TG, GBStonehouse, Jeffrey, Paul, C/o AstraZeneca IPAstraZeneca R&DAlderley Alderley Park, Macclesfield, Cheshire, SK10 4TG, GB(51) MKPC<strong>07</strong>D 405/12 (2006.01) (97) EP 2301933(96) EP 10194616.8 23.08.2005.(97) EP 2301933, 30.03.2011. 201113, En(31) 0419235 (32) 28.08.2004. (33) GB0502544 08.02.2005. GB(54) Thiopyrimidine derivative, useful as an intermediate forchemokine receptor modulators(71) AstraZeneca AB, , 151 85 Södertälje, SE(72) Cheshire, David, Ranulf, AstraZeneca R&D CharnwoodBakewellRoad, Loughborough, Leicestershire LE11 5RH, GBCox, Rhona, Jane, AstraZeneca R&D CharnwoodBakewell Road,Loughborough, Leicestershire LE11 5RH, GBMeghani, Premji, c/o AstraZeneca Intellectual PropertyAstraZenecaR&D AlderleyAlderley Park, Macclesfield, Cheshire SK10 4TG, GBPreston, Cherylin, FrancisC/o AstraZeneca IP, AstraZeneca R&DAlderley, Alderley Park, MacclesfieldCheshire, SK10 4TG, GBSmith, Michael, NealC/o AstraZeneca IP, AstraZeneca R&DAlderley, Alderley Park, MacclesfieldCheshire, SK10 4TG, GBStonehouse, Jeffrey, Paul, C/o AstraZeneca IPAstraZeneca R&DAlderley Alderley Park, Macclesfield, Cheshire, SK10 4TG, GB(51) MKPC<strong>07</strong>D 471/04 (2006.01) (97) EP 2468748A61K 31/438 (2006.01)A61P 35/00 (2006.01)C<strong>07</strong>D 491/04 (2006.01)C<strong>07</strong>D 495/04 (2006.01)(96) EP 12160548.9 15.02.20<strong>07</strong>.(97) EP 2468748, 27.06.2012. 201226, En(31) 773513 P (32) 15.02.2006. (33) US(54) Pyrazoloquinolones are potent parp inhibitors(71) AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USISSN 1847-3024

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!